Literature DB >> 15153717

Fludarabine combination regimen severely affected peripheral blood stem cell mobilization.

Daniele Laszlo1, Piero Galieni, Donatella Raspadori, Monica Tozzi, Francesco Lauria, Giovanni Martinelli.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15153717     DOI： 10.1159/000077572

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  7 in total

1.  Hematopoietic Progenitor Cell Harvesting Is Feasible after Treatment with Brentuximab Vedotin in CD30(+) Lymphoma Patients Who Received Multiple Prior Lines of Treatment.

Authors:  Manuel Afable; Paolo F Caimi; Chitra Hosing; Marcos de Lima; Issa Khouri; Basem M William; Yago Nieto; Brenda W Cooper; Paolo Anderlini; Stanton L Gerson; Hillard M Lazarus; Richard Champlin; Uday Popat
Journal:  Biol Blood Marrow Transplant       Date:  2015-04-30       Impact factor: 5.742

Review 2.  A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program.

Authors:  D Sheppard; C Bredeson; L Huebsch; D Allan; J Tay
Journal:  Bone Marrow Transplant       Date:  2014-03-10       Impact factor: 5.483

Review 3.  Advances in stem cell mobilization.

Authors:  Rusudan K Hopman; John F DiPersio
Journal:  Blood Rev       Date:  2014-01-14       Impact factor: 8.250

4.  Plerixafor in patients with lymphoma and multiple myeloma: effectiveness in cases with very low circulating CD34+ cell levels and preemptive intervention vs remobilization.

Authors:  I Sánchez-Ortega; S Querol; M Encuentra; S Ortega; A Serra; J M Sanchez-Villegas; J R Grifols; M M Pujol-Balaguer; M Pujol-Bosch; J M Martí; T Garcia-Cerecedo; P Barba; J M Sancho; A Esquirol; J Sierra; R F Duarte
Journal:  Bone Marrow Transplant       Date:  2014-09-15       Impact factor: 5.483

5.  Proposed definition of 'poor mobilizer' in lymphoma and multiple myeloma: an analytic hierarchy process by ad hoc working group Gruppo ItalianoTrapianto di Midollo Osseo.

Authors:  A Olivieri; M Marchetti; R Lemoli; C Tarella; A Iacone; F Lanza; A Rambaldi; A Bosi
Journal:  Bone Marrow Transplant       Date:  2011-05-30       Impact factor: 5.483

Review 6.  Increased mobilization and yield of stem cells using plerixafor in combination with granulocyte-colony stimulating factor for the treatment of non-Hodgkin's lymphoma and multiple myeloma.

Authors:  Louis M Pelus; Sherif S Farag
Journal:  Stem Cells Cloning       Date:  2011-02-27

Review 7.  Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.

Authors:  P Alvarez; E Carrillo; C Vélez; F Hita-Contreras; A Martínez-Amat; F Rodríguez-Serrano; H Boulaiz; R Ortiz; C Melguizo; J Prados; A Aránega
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.